Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603
side by side viewer icon HTML

Abstract

Introduction

During the COVID-19 pandemic, various complications have been reported in patients with this infection worldwide, including a wide range of neurological disorders. In this study, we have reported a novel neurological complication in a 46-years-old woman who was referred due to a headache following a mild COVID-19 infection. Also, we have had a quick review of previous reports of dural and leptomeningeal involvements in COVID-19 patients.

Case Report

The patient's headache was persistent, global, and compressive with radiation to the eyes. The severity of the headache was increased during the disease course and was exacerbated by walking, coughing, and sneezing but decreased with rest. The high severity of the headache disrupted the patient’s sleep. Neurological examinations were completely normal, and laboratory tests did not have abnormal findings except for an inflammatory pattern. Finally, in the brain MRI, a concurrent diffuse dural enhancement and leptomeningeal involvement were observed, which is a new finding in COVID-19 patients and has not been reported so far. The patient was hospitalized and treated with Methylprednisolone pulses. After completing the therapeutic course, she was discharged from the hospital in good condition and with an improved headache. A repeated brain MRI was requested 2 months after discharge, which was completely normal and showed no evidence of dural and leptomeningeal involvements.

Conclusion

Inflammatory complications of the central nervous system caused by COVID-19 can occur in different forms and types, and clinicians should consider them.

© 2024 The Author(s). Published by Bentham Open. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cmir/10.2174/1573405620666230328110847
2024-01-01
2025-01-20
Loading full text...

Full text loading...

/deliver/fulltext/cmir/20/1/CMIM-20-e280323215040.html?itemId=/content/journals/cmir/10.2174/1573405620666230328110847&mimeType=html&fmt=ahah

References

  1. ToturaAL BaricRS SARS coronavirus pathogenesis: Host innate immune responses and viral antagonism of interferon.Curr Opin Virol.20122326427510.1016/j.coviro.2012.04.004
    [Google Scholar]
  2. NassarM.S. BakhrebahM.A. MeoS.A. AlsuabeylM.S. ZaherW.A. Middle east respiratory syndrome coronavirus (MERS-CoV) infection: Epidemiology, pathogenesis and clinical characteristics.Eur. Rev. Med. Pharmacol. Sci.201822154956496130070331
    [Google Scholar]
  3. ElrobaaI.H. NewK.J. COVID-19: Pulmonary and extra pulmonary manifestations.Front. Public Health2021971161671161610.3389/fpubh.2021.71161634650947
    [Google Scholar]
  4. BodroM. ComptaY. Sánchez-ValleR. Presentations and mechanisms of CNS disorders related to COVID-19.Neurol. Neuroimmunol. Neuroinflamm.202181e92310.1212/NXI.000000000000092333310765
    [Google Scholar]
  5. Sancho-SaldañaA. Lambea-GilÁ. LiesaJ.L.C. CaballoM.R.B. GarayM.H. CeladaD.R. Serrano-PonzM. Guillain–Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.Clin. Med.2020204e93e9410.7861/clinmed.2020‑021332518103
    [Google Scholar]
  6. Di MuzioB. VaderaS. Meningeal enhancement.Radiopaedia202110.53347/rID‑36908
    [Google Scholar]
  7. RiverY. SchwartzA. GomoriJ.M. SofferD. SiegalT. Clinical significance of diffuse dural enhancement detected by magnetic resonance imaging.J. Neurosurg.199685577778310.3171/jns.1996.85.5.07778893714
    [Google Scholar]
  8. AntonyJ. HackingC. JeffreeR.L. Pachymeningeal enhancement—a comprehensive review of literature.Neurosurg. Rev.201538464965910.1007/s10143‑015‑0646‑y26264063
    [Google Scholar]
  9. TosakaM. SatoN. FujimakiH. TanakaY. KagoshimaK. TakahashiA. SaitoN. YoshimotoY. Diffuse pachymeningeal hyperintensity and subdural effusion/hematoma detected by fluid-attenuated inversion recovery MR imaging in patients with spontaneous intracranial hypotension.AJNR Am. J. Neuroradiol.20082961164117010.3174/ajnr.A104118417608
    [Google Scholar]
  10. NewmanN.J. JankovicJ. MazziottaJ.C. PomeroyS.L. Bradley’s neurology in clinical practice.Elsevier2021
    [Google Scholar]
  11. FadakarN GhaemmaghamiS MasoompourSM A first case of acute cerebellitis associated with coronavirus disease (COVID-19): A case report and literature review.Cerebellum202019691191410.1007/s12311‑020‑01177‑9
    [Google Scholar]
  12. Freire-ÁlvarezE. GuillénL. LambertK. BaidezA. García-QuesadaM. AndreoM. AlomJ. MasiáM. GutiérrezF. COVID-19-associated encephalitis successfully treated with combination therapy.Clin. Infect. Pract.20207-810005310.1016/j.clinpr.2020.10005333163956
    [Google Scholar]
  13. ChengF. TangK. A case of COVID-19 encephalitis with anti-gfap antibody-positive meningoencephalomyelitis.J. Neurol. Sci.202142911990810.1016/j.jns.2021.119908
    [Google Scholar]
  14. KhodamoradiZ. HosseiniS.A. Gholampoor SaadiM.H. MehrabiZ. SasaniM.R. YaghoubiS. COVID-19 meningitis without pulmonary involvement with positive cerebrospinal fluid PCR.Eur. J. Neurol.202027122668266910.1111/ene.1453632926584
    [Google Scholar]
  15. NazS. HanifM. HaiderM.A. AliM.J. AhmedM.U. SaleemS. Meningitis as an initial presentation of COVID-19: A case report.Front. Public Health2020847410.3389/fpubh.2020.0047433072684
    [Google Scholar]
  16. PackwoodR. GallettaG. TennysonJ. An unusual case report of COVID-19 presenting with meningitis symptoms and shingles.Clin. Pract. Cases Emerg. Med.20204331632010.5811/cpcem.2020.4.4755732926675
    [Google Scholar]
  17. Rodrigo-ArmenterosP. Uterga-ValienteJ.M. Zabala-Del-ArcoJ. Taramundi-ArgüesoS. Antón-MéndezL. Gómez-MugaJ.J. Garcia-MoncoJ.C. Optic neuropathy in a patient with COVID-19 infection.Acta Neurol. Belg.2022122378979110.1007/s13760‑021‑01600‑w33528821
    [Google Scholar]
  18. Rodríguez de AntonioL.A. González-SuárezI. Fernández-BarriusoI. Rabasa PérezM. Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review.Mult. Scler. Relat. Disord.20214910278310.1016/j.msard.2021.10278333513521
    [Google Scholar]
  19. TurbinR.E. WawrzusinP.J. SaklaN.M. TrabaC.M. WongK.G. MiraniN. EloyJ.A. NimchinskyE.A. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19.Orbit202039430531010.1080/01676830.2020.176856032419568
    [Google Scholar]
  20. VelonakisG. KaravasilisE. FilippiadisD.K. AlmyroudiM.P. KorompokiE. Leptomeningeal enhancement due to COVID-19 on 3D-FLAIR and T1 Black-Blood MR imaging sequences.AJNR Am. J. Neuroradiol.2021427E39E4110.3174/ajnr.A710433985953
    [Google Scholar]
  21. DixonL. VarleyJ. GontsarovaA. MallonD. TonaF. MuirD. LuqmaniA. JenkinsI.H. NicholasR. JonesB. EverittA. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.Neurol. Neuroimmunol. Neuroinflamm.202075e78910.1212/NXI.000000000000078932457227
    [Google Scholar]
  22. ElkadyA. RabinsteinA.A. Acute necrotizing encephalopathy and myocarditis in a young patient with COVID-19.Neurol. Neuroimmunol. Neuroinflamm.202075e80110.1212/NXI.0000000000000801
    [Google Scholar]
  23. VirhammarJ. KumlienE. FällmarD. FrithiofR. JackmannS. SköldM.K. KadirM. FrickJ. LindebergJ. Olivero-ReiniusH. RyttleforsM. CunninghamJ.L. WikströmJ. GrabowskaA. BondesonK. BergquistJ. ZetterbergH. RostamiE. Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid.Neurology2020951044544910.1212/WNL.000000000001025032586897
    [Google Scholar]
  24. NoviG. RossiT. PedemonteE. SaittaL. RollaC. RoccatagliataL. IngleseM. FarininiD. Acute disseminated encephalomyelitis after SARS-CoV-2 infection.Neurol. Neuroimmunol. Neuroinflamm.202075e79710.1212/NXI.000000000000079732482781
    [Google Scholar]
  25. DjellaouiA. SeddikL. Cleret De LangavantL. CattanS. Bachoud-LéviA.C. HosseiniH. Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection.J. Neurol. Neurosurg. Psychiatry202192111311410.1136/jnnp‑2020‑32392332718920
    [Google Scholar]
  26. LersyF. KremerS. Meningeal inflammation and cerebral vasculitis during acute COVID-19 with spontaneous regression.Intensive Care Med.202248223323510.1007/s00134‑021‑06592‑y34913085
    [Google Scholar]
  27. DoganL. KayaD. SarikayaT. ZenginR. DincerA. AkinciI.O. AfsarN. Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series.Brain Behav. Immun.20208715515810.1016/j.bbi.2020.05.02232389697
    [Google Scholar]
  28. PalaoM. Fernández-DíazE. Gracia-GilJ. Romero-SánchezC.M. Díaz-MarotoI. SeguraT. Multiple sclerosis following SARS-CoV-2 infection.Mult. Scler. Relat. Disord.20204510237710.1016/j.msard.2020.10237732698095
    [Google Scholar]
  29. ZhouS. Jones-LopezE.C. SonejiD.J. AzevedoC.J. PatelV.R. Myelin oligodendrocyte glycoprotein antibody–associated optic neuritis and myelitis in COVID-19.J. Neuroophthalmol.202040339840210.1097/WNO.000000000000104932604245
    [Google Scholar]
  30. WesthoffT.H. SeibertF.S. BauerF. StervboU. AnftM. DoevelaarA.A.N. RohnB.J. WinnekendonkG. DittmerU. SchenkerP. VonbrunnE. AmannK. ViebahnR. BabelN. Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient.Am. J. Transplant.202020113216322010.1111/ajt.1622332713123
    [Google Scholar]
  31. RebeizT. Lim-HingK. KhazanehdariS. RebeizK. Behavioral changes without respiratory symptoms as a presenting sign of COVID-19 encephalitis.Cureus2020129e1046910.7759/cureus.1046933083172
    [Google Scholar]
/content/journals/cmir/10.2174/1573405620666230328110847
Loading
/content/journals/cmir/10.2174/1573405620666230328110847
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test